Mar 11, 2021 / 02:35PM GMT
Anthony Charles Petrone - Jefferies LLC, Research Division - Healthcare Analyst
Thank you, everyone, for joining us for the Global Plasma Summit here hosted by Jefferies. Up next, we're happy to introduce Amir London, CEO of Kamada. We have a 30-minute session. Amir will have a presentation for the entirety of the 30 minutes. If we have a few minutes toward the end, we can go to Q&A. Amir, thank you for joining us.
Amir London - Kamada Ltd. - CEO
Of course. Thank you, Anthony, and thank you, all of you for joining us today. As Anthony mentioned, I will be presenting Kamada and I'm very honored for this invitation by Jefferies for the first Plasma Summit. Thank you very much for the opportunity.
So Kamada is a global specialty plasma-derived biopharmaceutical company. We are doing trading on the NASDAQ and Tel Aviv Exchange. 2 FDA approved product, the first one, GLASSIA in 2010; second one, KEDRRAB of 2017, and I will go through this portfolio in a minute.
In addition, we, of course, have products which are under clinical development. And
Kamada Ltd at Jefferies Virtual Plasma Summit Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers